# Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer

> **NCT00625937** · PHASE2 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 46 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** docetaxel
- **DRUG:** tegafur-gimeracil-oteracil potassium
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00625937
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-11
- **Primary completion:** 2010-11
- **Final completion:** —
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2011-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00625937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00625937, "Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00625937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*